Literature DB >> 29107654

Effectiveness of varicella vaccine as post-exposure prophylaxis during a varicella outbreak in Shanghai, China.

Qiang-Song Wu1, Jing-Yi Liu1, Xian Wang1, Yuan-Fang Chen1, Qi Zhou1, An-Qi Wu1, Lan Wang2.   

Abstract

OBJECTIVES: Varicella vaccine (VarV) is recommended as effective post-exposure prophylaxis (PEP) within 3-5days to control outbreaks. However, the effectiveness of PEP at >5days after exposure and the administration of a second dose to those with a history of one dose prior to exposure have not been fully examined. This study evaluated the vaccine effectiveness (VE) of PEP in preventing disease during a varicella outbreak in Shanghai, China in 2013.
METHODS: Self-administered questionnaires were used to obtain the students' varicella history, vaccination status, and willingness to receive PEP. One dose of VarV was provided free of charge to eligible students. The VE of PEP was calculated as [1-relative risk (RR)]×100%. Analyses were restricted to grade 8 students, as no students from the other grades or teachers developed varicella during the outbreak.
RESULTS: Twenty-seven varicella cases were identified, 16 (59%) of which were infected after the PEP campaign. Sixty-five students received one dose of VarV on day 13 or 19 after the index case. Attack rates were 28% (9/32), 16% (15/94), 0% (0/10), and 6% (3/55) among unvaccinated, one-dose Pre-PEP, first dose as PEP, and second dose as PEP recipients, respectively. Cases among second dose as PEP recipients tended to have less fever compared with unvaccinated or one-dose Pre-PEP recipients. Compared with unvaccinated students, the VE of first dose as PEP recipients was 100% and of the second dose as PEP recipients was 60% (95% confidence interval -72% to 91%).
CONCLUSIONS: Post-exposure vaccination should be given as soon as possible after exposure. Nevertheless, vaccination is still recommended even at more than 5days post-exposure to control varicella outbreaks.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Outbreak; Post-exposure prophylaxis; Vaccine effectiveness; Varicella vaccine

Mesh:

Substances:

Year:  2017        PMID: 29107654     DOI: 10.1016/j.ijid.2017.10.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  6 in total

1.  Analysis of sero-epidemiological characteristics of varicella in healthy children in Jiangsu Province, China.

Authors:  Lei Zhang; Wang Ma; Yuanbao Liu; Yong Wang; Xiang Sun; Ying Hu; Xiuying Deng; Peishan Lu; Fenyang Tang; Zhiguo Wang; Minghao Zhou
Journal:  BMC Infect Dis       Date:  2018-11-14       Impact factor: 3.090

Review 2.  Postexposure Effects of Vaccines on Infectious Diseases.

Authors:  Tara Gallagher; Marc Lipsitch
Journal:  Epidemiol Rev       Date:  2019-01-31       Impact factor: 6.222

3.  Effectiveness of varicella vaccine as post-exposure prophylaxis: a meta-analysis.

Authors:  Daoyong Chen; Yue Li; Qiangsong Wu
Journal:  Hum Vaccin Immunother       Date:  2021-12-10       Impact factor: 3.452

4.  Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study.

Authors:  Yong Wang; Lei Zhang; Xiang Sun; Yang Cao; Zhiguo Wang; Li Liu; Yan Xu; Minghao Zhou; Yuanbao Liu
Journal:  Hum Vaccin Immunother       Date:  2019-10-07       Impact factor: 3.452

5.  Factors Influencing the Size and Duration of School Varicella Outbreaks in Shanghai, China, in the Era of Voluntary Single-Dose Vaccination.

Authors:  Qiangsong Wu; Linwei Zhang; Jingyi Liu; Yuanfang Chen; Qi Zhou; Zeliang Xuan; Yi Hu
Journal:  Open Forum Infect Dis       Date:  2019-09-21       Impact factor: 3.835

6.  Research about the optimal strategies for prevention and control of varicella outbreak in a school in a central city of China: based on an SEIR dynamic model.

Authors:  Wen-Ting Zha; Feng-Rui Pang; Nan Zhou; Bin Wu; Ying Liu; Yan-Bing Du; Xiu-Qin Hong; Yuan Lv
Journal:  Epidemiol Infect       Date:  2020-03-17       Impact factor: 2.451

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.